Insider Stock Trading History of Mayleben Timothy M


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Mayleben Timothy M since year 2005. The trader's CIK number is 1242613. At the time of this reporting, Mayleben Timothy M is the President & CEO of Esperion Therapeutics, Inc. . (stock ticker symbol ESPR). See this page for all insider trading activities at Esperion Therapeutics, Inc. .

Note that in the past MAYLEBEN TIMOTHY M also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Mayleben Timothy M since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2016-05-04 ESPR Esperion Therapeutics, Inc. Buy 7,000 14.85 103,950
2016-01-27 ESPR Esperion Therapeutics, Inc. Buy 3,600 15.88 57,168
2016-01-15 ESPR Esperion Therapeutics, Inc. Buy 7,200 14.08 101,376
2015-07-16 MRNS Marinus Pharmaceuticals Inc Option Ex 42,550 1.04 44,252
2013-07-01 ESPR Esperion Therapeutics, Inc. Buy 5,000 14.00 70,000
2011-08-08 ASTM Aastrom Biosciences Inc Buy 10,000 2.11 21,100
2011-08-05 ASTM Aastrom Biosciences Inc Buy 20,000 2.36 47,200
2011-03-02 ASTM Aastrom Biosciences Inc Buy 6,550 2.09 13,682
2011-03-03 ASTM Aastrom Biosciences Inc Buy 14,832 2.14 31,681
2010-11-24 ASTM Aastrom Biosciences Inc Buy 12,000 2.20 26,339
2010-08-30 ASTM Aastrom Biosciences Inc Buy 17,200 1.45 24,940
2010-05-21 ASTM Aastrom Biosciences Inc Buy 17,600 1.42 24,992
2010-03-05 ASTM Aastrom Biosciences Inc Buy 17,206 1.45 24,983
2010-03-08 ASTM Aastrom Biosciences Inc Buy 16,750 1.47 24,622
2006-08-15 NHWK Nighthawk Radiology Holdings Inc Buy 2,000 16.10 32,200
2006-08-16 NHWK Nighthawk Radiology Holdings Inc Buy 2,000 16.48 32,950

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mayleben Timothy M (President & CEO of Esperion Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.